Plavix Patent Upheld By Court, Blocking Generic Clopidogrel
This article was originally published in The Pink Sheet Daily
Executive Summary
Apotex says it will immediately appeal the decision in favor of Sanofi-Aventis/Bristol-Myers Squibb.
You may also be interested in...
Stop The Bleeding: Sanofi-Aventis Looks To Sell A Generic Plavix In Europe
If a bioequivalent version of the clot buster launches in France, Sanofi is preparing to roll out its own generic version of clopidogrel.
Stop The Bleeding: Sanofi-Aventis Looks To Sell A Generic Plavix In Europe
If a bioequivalent version of the clot buster launches in France, Sanofi is preparing to roll out its own generic version of clopidogrel.
Apotex Seeks To Maintain 156 Days Of Exclusivity For Generic Plavix
Apotex petitions FDA to stay action on other clopidogrel ANDAs, as Dr. Reddy’s gets into position for a generic launch.